Hybrid Type 2 Implementation-Effectiveness Trial of a Third Wave Virtual Reality Treatment for Youth Depression/Anxiety

Launched by ORYGEN · Mar 19, 2025

Keywords

ClinConnect Summary

Youth mental ill-health is a global crisis. One in five young people experience a mental health disorder every year, and suicide is a leading cause of death in this age group. In addition to costing the global economy $1 trillion per year in lost productivity, mental ill-health can have a severe and long-lasting impact on the lives of young people. Despite this, only a small proportion receive access to care, and of those that do, most fail to fully recover.

Technology has the potential to overcome many systemic barriers to accessing quality, sustainable care and importantly provide treatm...

Gender

ALL

Eligibility criteria

• There are three populations recruited for this trial:
• • INCLUSION CRITERIA
• • Young people
• • 1. Aged between 12-25 years (inclusive)
• • 2. Current client of a participating youth mental health service
• • 3. Seeking or receiving treatment for depression and/or anxiety
• • 4. Sufficient command of the English language
• • Clinicians Employed at a participating youth mental health service and involved in the delivery of psychological treatment of young people presenting with depression and anxiety
• • Service staff Work within a participating youth mental health service in a leadership (team lead or service manager) or administrative role.
• EXCLUSION CRITERIA:
• • Young people
• • 1. Moderate or severe audio or visual condition precluding engagement with the VR equipment (assessed on a case-by-case basis)
• • 2. Counter indication based on clinical judgement e.g., active suicidal risk or intellectual disability.
• • Clinicians Unable to commit to delivering the MIND intervention (5 sessions over 10-12 weeks).
• • Service staff Nil

Trial Officials